Prostate cancer screening for men over 70 is complex, with current recommendations against routine PSA testing due to slow ...

A 75-year-old man, Mr. A, had prostate cancer that had metastasized to his pelvis and spine. Despite attempts with multiple ...

Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about ...

In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

When prostate cancer spreads beyond the prostate gland to other parts of the body, it becomes what medical professionals call metastatic prostate cancer. This advanced form of the disease represents a ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...

Sept. 18, 2025 -- About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black ...

SCREENING men for prostate cancer could slash deaths by 13 per cent, saving thousands of lives a year, a study suggests.

Adding Xtandi to androgen deprivation therapy and radiation did not significantly improve metastasis-free survival in ...

Clinical and pathologic characteristics of mCRPC were largely similar between younger and older patients. Overall survival was not significantly different between younger and older patients with mCRPC ...

Prostate cancer screening could prevent around 1,500 deaths a year in the UK, research suggests. A European trial, one of the ...